Timed, pulsatile release systems
First Claim
1. A pharmaceutical multiparticulate dosage form comprising a mixture of immediate release (IR) beads and timed, pulsatile release (TPR) beads, wherein said TPR beads comprise:
- a) a core particle comprising one or more basic, active pharmaceutical ingredients or pharmaceutically acceptable salts thereof;
b) an inner barrier coating surrounding said core particle, said barrier coating comprising;
i) an enteric polymer, or ii) a water-insoluble polymer alone or in combination with a water-soluble pore-forming polymer; and
c) an outer lag-time coating comprising a water-insoluble polymer in combination with an enteric polymer, said outer membrane providing a lag time of at least about 5 hours before onset of drug release.
11 Assignments
0 Petitions
Accused Products
Abstract
A unit multiparticulate dosage form for delivering one or more basic, active pharmaceutical ingredients into the body in need of such medications to achieve target PK (pharmacokinetics) profiles is described. The dosage form comprises one or more multicoated drug particles (beads, pellets, mini-/micro-tablets) having a barrier coating and a lag-time coating. Each Timed Pulsatile Release (TPR) bead population exhibits pre-determined lag-time followed by differing release characteristics. The composition and thickness of the barrier coating, composition and thickness of the lag-time coating, ratio of IR beads to one or more TPR bead populations and total dose may be varied depending on the alkalinity, pH-dependent solubility and elimination half-life of the active ingredients to achieve target PK profiles (suitable for a once or twice daily dosing regimen) in patients in need of such medications.
121 Citations
23 Claims
-
1. A pharmaceutical multiparticulate dosage form comprising a mixture of immediate release (IR) beads and timed, pulsatile release (TPR) beads, wherein said TPR beads comprise:
-
a) a core particle comprising one or more basic, active pharmaceutical ingredients or pharmaceutically acceptable salts thereof;
b) an inner barrier coating surrounding said core particle, said barrier coating comprising;
i) an enteric polymer, or ii) a water-insoluble polymer alone or in combination with a water-soluble pore-forming polymer; and
c) an outer lag-time coating comprising a water-insoluble polymer in combination with an enteric polymer, said outer membrane providing a lag time of at least about 5 hours before onset of drug release. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 22, 23)
-
-
18. A method for the preparation of a multiparticulate dosage form comprising:
-
a) preparing IR (immediate-release) beads comprising one or more basic active pharmaceutical ingredients or pharmaceutically acceptable salts thereof;
b) applying a barrier coating on said IR beads, said barrier coating comprising an enteric polymer or a water-insoluble polymer for a weight gain of from about 1.5% to 20% by dry weight of the coated bead;
c) applying an outer lag-time coating comprising a water-insoluble polymer in combination with an enteric polymer at a ratio of from about 10;
1 to 1;
2, respectively, for a weight gain of from about 30% to 60% by dry weight of the coated bead to form a Timed, Pulsatile Release (TPR) bead; and
d) filling into gelatin capsules or compressing into conventional tablets or ODTs (orally disintegrating tablets) one or more TPR bead populations at appropriate amounts to achieve target PK (pharmacokinetics) profiles (suitable for a once- or twice daily dosing regimen) in patients in need of such active pharmaceutical ingredients. - View Dependent Claims (19, 20, 21)
-
Specification